Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Playing the devil’s advocate: Should we give a second chance to mTOR inhibition in renal clear cell carcinoma? – ie strategies to revert resistance to mtor inhibitors

Title: Playing the devil’s advocate: Should we give a second chance to mTOR inhibition in renal clear cell carcinoma? – ie strategies to revert resistance to mtor inhibitors
Authors: Pezzicoli G.; Filoni E.; Gernone A.; Cosmai L.; Rizzo M.; Porta C.
Contributors: Pezzicoli, G.; Filoni, E.; Gernone, A.; Cosmai, L.; Rizzo, M.; Porta, C.
Publication Year: 2021
Collection: Università degli Studi di Bari Aldo Moro: CINECA IRIS
Subject Terms: Anti-angiogenic; Autophagy; Everolimu; Rapa-Link; Temsirolimus
Description: In the last decade, the inhibition of the mechanistic target of Rapamycin (mTOR) in renal clear cell carcinoma (RCC) has disappointed the clinician’s expectations. Many clinical trials highlighted the low efficacy and unmanageable safety profile of first-generation mTOR inhibitors (Rapalogs), thus limiting their use in the clinical practice only to those patients who already failed several therapy lines. In this review, we analyze the major resistance mechanisms that undermine the efficacy of this class of drugs. Moreover, we describe some of the possible strategies to overcome the mechanisms of resistance and their clinical experimentation, with particular focus on novel mTOR inhibitors and the combina-tions of mTOR inhibitors and other anti-cancer drugs.
Document Type: article in journal/newspaper
Language: English
Relation: info:eu-repo/semantics/altIdentifier/pmid/34675658; info:eu-repo/semantics/altIdentifier/wos/WOS:000705483400002; volume:13; firstpage:7623; lastpage:7636; numberofpages:14; journal:CANCER MANAGEMENT AND RESEARCH; https://hdl.handle.net/11586/389081
DOI: 10.2147/CMAR.S267220
Availability: https://hdl.handle.net/11586/389081; https://doi.org/10.2147/CMAR.S267220; https://www.dovepress.com/playing-the-devils-advocate-should-we-give-a-second-chance-to-mtor-inh-peer-reviewed-fulltext-article-CMAR
Rights: info:eu-repo/semantics/openAccess ; license:Creative commons ; license uri:http://creativecommons.org/licenses/by-nc/4.0/
Accession Number: edsbas.FA105939
Database: BASE